250 related articles for article (PubMed ID: 21851625)
1. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.
Yeung S; Patouillard E; Allen H; Socheat D
Malar J; 2011 Aug; 10():243. PubMed ID: 21851625
[TBL] [Abstract][Full Text] [Related]
2. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.
Littrell M; Gatakaa H; Phok S; Allen H; Yeung S; Chuor CM; Dysoley L; Socheat D; Spiers A; White C; Shewchuk T; Chavasse D; O'Connell KA
Malar J; 2011 Oct; 10():328. PubMed ID: 22039922
[TBL] [Abstract][Full Text] [Related]
3. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
[TBL] [Abstract][Full Text] [Related]
4. Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies.
; Phok S; Lek D
Malar J; 2017 Apr; 16(1):171. PubMed ID: 28438204
[TBL] [Abstract][Full Text] [Related]
5. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
[TBL] [Abstract][Full Text] [Related]
7. Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention.
Willey BA; Tougher S; Ye Y; ; Mann AG; Thomson R; Kourgueni IA; Amuasi JH; Ren R; Wamukoya M; Rueda ST; Taylor M; Seydou M; Nguah SB; Ndiaye S; Mberu B; Malam O; Kalolella A; Juma E; Johanes B; Festo C; Diap G; Diallo D; Bruxvoort K; Ansong D; Amin A; Adegoke CA; Hanson K; Arnold F; Goodman C
Malar J; 2014 Feb; 13():46. PubMed ID: 24495691
[TBL] [Abstract][Full Text] [Related]
8. Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.
Lussiana C
Health Policy Plan; 2016 Sep; 31(7):928-39. PubMed ID: 25862732
[TBL] [Abstract][Full Text] [Related]
9. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
; Tougher S; Hanson K; Goodman C
Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
[TBL] [Abstract][Full Text] [Related]
10. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
[TBL] [Abstract][Full Text] [Related]
11. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
; Mpanya G; Tshefu A; Likwela JL
Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
[TBL] [Abstract][Full Text] [Related]
12. Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys.
Bennett A; Bisanzio D; Yukich JO; Mappin B; Fergus CA; Lynch M; Cibulskis RE; Bhatt S; Weiss DJ; Cameron E; Gething PW; Eisele TP
Lancet Glob Health; 2017 Apr; 5(4):e418-e427. PubMed ID: 28288746
[TBL] [Abstract][Full Text] [Related]
13. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
[TBL] [Abstract][Full Text] [Related]
14. The ACTwatch project: methods to describe anti-malarial markets in seven countries.
Shewchuk T; O'Connell KA; Goodman C; Hanson K; Chapman S; Chavasse D
Malar J; 2011 Oct; 10():325. PubMed ID: 22039780
[TBL] [Abstract][Full Text] [Related]
15. The Affordable Medicines Facility-malaria--a success in peril.
Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
17. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management.
Chanda P; Hamainza B; Moonga HB; Chalwe V; Banda P; Pagnoni F
Malar J; 2011 Jun; 10():159. PubMed ID: 21651828
[TBL] [Abstract][Full Text] [Related]
18. The malaria testing and treatment landscape in mainland Tanzania, 2016.
; Michael D; Mkunde SP
Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
[TBL] [Abstract][Full Text] [Related]
19. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.
Thomson R; Festo C; Johanes B; Kalolella A; Bruxvoort K; Nchimbi H; Tougher S; Cairns M; Taylor M; Kleinschmidt I; Ye Y; Mann A; Ren R; Willey B; Arnold F; Hanson K; Kachur SP; Goodman C
PLoS One; 2014; 9(5):e95607. PubMed ID: 24816649
[TBL] [Abstract][Full Text] [Related]
20. The malaria testing and treatment landscape in Benin.
; Zinsou C; Cherifath AB
Malar J; 2017 Apr; 16(1):174. PubMed ID: 28446236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
